-Bennett S,
Dougherty MJ, Calligaro KD. Duplex ultrasound factors
predicting persistent type II endoleak and increasing AAA
sac diameter after EVAR. J Vasc Surg 2010;52:1147-52.
657. Rayt HS, Sandford RM, Salem M, Bown MJ, London NJ,
Sayers RD. Conservative management of type 2 endoleaks
is not associated with increased risk of aneurysm rupture.
Eur J Vasc Endovasc Surg 2009;38:718-23.
658. Zhou W, Blay E Jr, Varu V, Ali S, Jin MQ, Sun L, et al.
Outcome and clinical signiÔ¨Åcance of delayed endoleaks
after endovascular aneurysm repair. J Vasc Surg 2014;59:
915-20.
659. Sidloff DA, Gokani V, Stather PW, Choke E, Bown MJ,
Sayers RD. Type II endoleak: conservative management is a
safe strategy. Eur J Vasc Endovasc Surg 2014;48:391-9.
660. Mansueto G, Cenzi D, Scuro A, Gottin L, Griso A, Gumbs AA,
et al. Treatment of type II endoleak with a transcatheter
transcaval approach: results at 1-year follow-up. J Vasc Surg
2007;45:1120-7.
661. Giles KA, Fillinger MF, De Martino RR, Hoel AW, Powell RJ,
Walsh DB. Results of transcaval embolization for sac
expansion from type II endoleaks after endovascular
aneurysm repair. J Vasc Surg 2015;61:1129-36.
662. Richardson WS, Sternbergh WC 3rd, Money SR. Laparoscopic inferior mesenteric artery ligation: an alternative for
the treatment of type II endoleaks. J Laparoendosc Adv
Surg Tech A 2003;13:355-8.
663.